Formycin B influx studies have shown that P388 and L1210 mouse
leukemia cells, mouse L929 cells, mouse RAW 309 Cr.1 cells, LK35.2 mouse B-cell hybridoma cells and cultured mouse peritoneal macrophages express both Na(+)-dependent, active and nonconcentrative, facilitated
nucleoside transport systems. In the mouse cell lines, active transport represented only a minor
nucleoside transport component and was detected only by measuring
formycin B uptake in the presence of
dipyridamole or nitrobenzylthioinosine, strong inhibitors of facilitated, but not of active,
nucleoside transport. Inhibition of facilitated transport resulted in the concentrative accumulation of
formycin B in cells expressing active
nucleoside transport. Concentrative
formycin B accumulation was abolished by treatment of the cells with
gramicidin or absence of Na+ in the extracellular medium and strongly inhibited by
ATP depletion or
ouabain treatment. Mouse macrophages accumulated
formycin B to 70-times the extracellular concentration in the absence of
dipyridamole during 90 min of incubation at 37 degrees C. Thus active transport represents a major
nucleoside transport system of these cells, similarly as previously reported for mouse spleen lymphocytes. In contrast to the various types of mouse cells, active
formycin B transport was not detected in human HeLa cells, human H9, Jurkat and CEM T lymphoidal cells and pig spleen lymphocytes. These cells expressed only facilitated
nucleoside transport with kinetic properties similar to those of the facilitated transporters of other mammalian cells.